Cancer discovery · 2011
Temporal dissection of tumorigenesis in primary cancers.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Durinck Steffen, Ho Christine, Wang Nicholas J, Liao Wilson, Jakkula Lakshmi R, Collisson Eric A, Pons Jennifer, Chan Sai-Wing, Lam Ernest T, Chu Catherine, Park Kyunghee, Hong Sung-woo, Hur Joe S, Huh Nam, Neuhaus Isaac M, Yu Siegrid S, Grekin Roy C, Mauro Theodora M, Cleaver James E, Kwok Pui-Yan, LeBoit Philip E, Getz Gad, Cibulskis Kristian, Aster Jon C, Huang Haiyan, Purdom Elizabeth, Li Jian, Bolund Lars, Arron Sarah T, Gray Joe W, Spellman Paul T, Cho Raymond J
Аннотация
Timely intervention for cancer requires knowledge of its earliest genetic aberrations. Sequencing of tumors and their metastases reveals numerous abnormalities occurring late in progression. A means to temporally order aberrations in a single cancer, rather than inferring them from serially acquired samples, would define changes preceding even clinically evident disease. We integrate DNA sequence and copy number information to reconstruct the order of abnormalities as individual tumors evolve for 2 separate cancer types. We detect vast, unreported expansion of simple mutations sharply demarcated by recombinative loss of the second copy of TP53 in cutaneous squamous cell carcinomas (cSCC) and serous ovarian adenocarcinomas, in the former surpassing 50 mutations per megabase. In cSCCs, we also report diverse secondary mutations in known and novel oncogenic pathways, illustrating how such expanded mutagenesis directly promotes malignant progression. These results reframe paradigms in which TP53 mutation is required later, to bypass senescence induced by driver oncogenes.